Literature DB >> 10836343

Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS.

A G Lenz1, P G Jorens, B Meyer, W De Backer, F Van Overveld, L Bossaert, K L Maier.   

Abstract

Oxidative stress in acute respiratory distress syndrome (ARDS) is considered as an important pathophysiological mechanism in acute impairment of lung function. The present study investigated whether a pulmonary oxidant-antioxidant imbalance is indicated by substantial oxidative modification of proteins in bronchoalveolar lavage (BAL) fluid. Oxidatively modified proteins in BAL fluid, as measured by the reduction of protein carbonyl groups with tritiated borohydride, were studied in control subjects, patients with clinically established ARDS, and patients considered at-risk for ARDS because they had had coronary bypass surgery. Subsets of these at-risk patients were pretreated either with methylprednisolone or N-acetylcysteine. The carbonyl content of BAL fluid proteins was greatly increased in ARDS patients (5.0+/-13 nmol carbonyl x mL(-1) BAL fluid; mean+/-SEM; p=0.0004; n=10) and moderately increased in the untreated patients at-risk for ARDS (1.3+/-0.2 nmol x mL(-1); p=0.027; n=19) compared with controls (0.8+/-0.2 nmol x mL(-1); n=12). The two other at-risk groups pretreated either with methylprednisolone or N-acetylcysteine showed carbonyl values that were statistically not different from the controls (1.2+/-0.2 nmol x mL(-1); p=0.13; n=13, and 1.1+/-0.3 nmol x mL(-1); p=0.40; n=8, respectively). These results show that oxidatively modified proteins clearly accumulated in bronchoalveolar lavage fluid of acute respiratory distress syndrome patients, and to a minor extent in untreated at-risk patients. These data suggest a severe oxidant-antioxidant imbalance in acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10836343     DOI: 10.1034/j.1399-3003.1999.13a31.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.

Authors:  K Nagai; T Betsuyaku; T Kondo; Y Nasuhara; M Nishimura
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 2.  Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace.

Authors:  Louise Hecker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

3.  Oxidative and nitrosative modifications of tropoelastin prevent elastic fiber assembly in vitro.

Authors:  Kamal Akhtar; Thomas J Broekelmann; Ming Miao; Fred W Keeley; Barry C Starcher; Richard A Pierce; Robert P Mecham; Tracy L Adair-Kirk
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 4.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

5.  The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.

Authors:  Philip T James; Zakari Ali; Andrew E Armitage; Ana Bonell; Carla Cerami; Hal Drakesmith; Modou Jobe; Kerry S Jones; Zara Liew; Sophie E Moore; Fernanda Morales-Berstein; Helen M Nabwera; Behzad Nadjm; Sant-Rayn Pasricha; Pauline Scheelbeek; Matt J Silver; Megan R Teh; Andrew M Prentice
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.798

6.  Protective action of taurine, given as a pretreatment or as a posttreatment, against endotoxin-induced acute lung inflammation in hamsters.

Authors:  Tapan M Bhavsar; Sanket N Patel; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 7.  Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence.

Authors:  Annika Höhn; Daniela Weber; Tobias Jung; Christiane Ott; Martin Hugo; Bastian Kochlik; Richard Kehm; Jeannette König; Tilman Grune; José Pedro Castro
Journal:  Redox Biol       Date:  2016-12-07       Impact factor: 11.799

8.  Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.

Authors:  Akhila Viswan; Chandan Singh; Ratan Kumar Rai; Afzal Azim; Neeraj Sinha; Arvind Kumar Baronia
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

9.  Statins as a novel therapeutic strategy in acute lung injury.

Authors:  Sunit Singla; Jeffrey R Jacobson
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

10.  Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy.

Authors:  Marika Crohns; Seppo Saarelainen; Hannu Kankaanranta; Eeva Moilanen; Hannu Alho; Pirkko Kellokumpu-Lehtinen
Journal:  Free Radic Res       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.